Provectus Biopharmaceuticals Inc (QB) (PVCT) Fundamentals

Provectus Biopharmaceuticals is a clinical-stage biotechnology company developing a new class of drugs for oncology, hematology, and dermatology based on an entire, wholly-owned, family of chemical small molecules called halogenated xanthenes. Intratumoral (aka intralesional) PV-10, the first small molecule autolytic immunotherapy, which can induce immunogenic cell death, is undergoing clinical study for adult solid tumor cancers, such as melanoma and GI tumors (e.g., hepatocellular carcinoma, metastatic colorectal cancer, metastatic neuroendocrine tumors, metastatic uveal melanoma), and preclinical study for pediatric solid tumor cancers (e.g., neuroblastoma, Ewing sarcoma, rhabdomyosarcoma, osteosarcoma) and blood cancers (e.g., acute myeloid leukemia). Topical PH-10 is undergoing clinical study for inflammatory dermatoses (e.g., psoriasis, atopic dermatitis). Information about these and the Company's other clinical trials can be found at the NIH registry, For additional information about Provectus, please visit the Company's website at
Share Info
Market Cap$ 23,177,216
Shares Authorized1,000,000,000
Shares Outstanding419,497,119
Shares Outstanding Date08/05/2022
Shareholder Count81
Shareholder Count Date03/29/2022
Float Date12/31/2021
Short Interest7
Short Interest Date07/15/2022
Reporting Info
Reporting StatusSEC Reporting
Audit StatusYes
AuditorMarcum LLP
Auditor Address730 Third Ave
New York, New York 10017
Auditor Website
IR Firm-
IR Firm Address-
IR Firm Website-
Legal CounselBaker Donelson Bearman Caldwell & Berkowitz
Legal Counsel Address211 Commerce Street
Suite 800
Nashville, Tennessee 37201
Legal Counsel
Fiscal Year End12/31
ADR Ratio-
Transfer AgentBroadridge Financial Solutions, Inc.
Transfer Agent Address51 Mercedes Way
Suite 1300
Philadelphia, PA 11717
Depository Website
SHO Flag-
3210 Flag-
Company Info
Ticker SymbolUSOTC:PVCT
OTC Market TierOTCQB
Security TypeCommon Stock
CIK Number0000315545
Address10025 Investment Drive
Suite 250
Knoxville, Tennessee 37932
Phone(866) 594-5999
Fax #866-998-0005
SIC Code / Description2834 / Pharmaceutical preparations
Key ExecutivesCTO - Eric Wachter, Ph.D.
Chairman - Webster Bailey
CFO - Heather Raines
Dir. - John Lacey
Chairman - Ed Pershing
Dir. - Bruce Horowitz
Vice Chairman - Dominic Rodrigues
Number of Employees4
Incorporation StateDelaware
Incorporation CountryUSA
Incorporation Year-

Your Recent History
Provectus ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.